The US Blood Transfusion Diagnostics Market

Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Scope and SegmentationMarket Segmentation Key Questions This Study Will AnswerMarket Engineering MeasurementsCEO’s PerspectiveKey Companies to WatchKey Companies to Watch (continued)Executive Summary—2 Big PredictionsExecutive Summary—2 Big Predictions (continued)Executive Summary—2 Big Predictions (continued)Market OverviewMarket BackgroundMarket Background—Types of Blood Bank AnalyzersMarket Background—Types of Blood Bank Analyzers (continued)Market Background—Types of Blood Bank Analyzers (continued)Comparison of Immunohematology MethodsVoice of Customer—Factors Governing Equipment Purchase for a Transfusion LaboratoryVoice of CustomerMarket Segmentation Procurement ProcessDefining Future Healthcare TrendsCompetitive PlaybookNew Market OpportunitiesNew Market Opportunities (continued)Drivers, Restraints, and Trends—Total Blood Transfusion Diagnostics MarketMarket DriversMarket RestraintsMarket Impact of Top 6 TrendsForecasts and Trends—Total Blood Transfusion Diagnostics MarketMarket Engineering MeasurementsMarket Engineering Measurements (continued)Factors Impacting Market ForecastsRevenue ForecastRevenue Forecast DiscussionBlood Grouping Segment AnalysisRevenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and ScreeningMedicare Expenditure for Abo, Rh, and RBC Antigen TypingTest Volume and Pricing Analysis for Blood Grouping TestsTest Volume and Pricing Analysis for Blood Grouping Tests (continued)Medicare Expenditure for Antibody Screening, Identification, and Cross Matching Disease Screening Segment Analysis Revenue ForecastRevenue Forecast for Serological and MolecularRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Test Volume and Pricing Analysis for Disease Screening and NAT TestsTest Volume Serological Donor Screening TestsTest Volume Serological Donor Screening Tests (continued)Cost Comparison per Test for Serological and NATMost Frequently Ordered Blood Tests by RankAccredited Transfusion CentersAccredited Immunohematology Reference LaboratoriesAccredited Immunohematology Reference Laboratories (continued)Accredited Immunohematology Reference Laboratories (continued)Accredited Immunohematology Reference Laboratories (continued)Accredited Immunohematology Reference Laboratories (continued)Blood Transfusion Centers Overview of Blood Bank Supply ChainOverview of Supply Chain in Blood BanksOverview of Supply Chain in Blood Banks (continued)Problem Areas and Solution Competitive EnvironmentMarket ShareMarket Share AnalysisProduct Analysis Blood GroupingProduct Analysis Blood Grouping (continued)Product Analysis Disease Screening (Serological and Molecular)Product Analysis Disease Screening (Molecular Assays)Merger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Company ProfilesImmucorOrtho Clinical DiagnosticsBeckman Coulter (Danaher) BioRadKey Companies to WatchQuotient Limited (previously known as Alba Bioscience)ImmucorDiagast 3Ti (Transfusion & Transplantation Technologies)The Last WordThe Last Word—2 Big PredictionsThe Last Word—DiscussionThe Last Word—Discussion (continued)Legal DisclaimerAppendixDrivers ExplainedDrivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Restraints Explained (continued)Restraints Explained (continued)Restraints Explained (continued)Additional Studies of InterestAdditional Studies of Interest (continued)Market Engineering MethodologyLearn More—Next StepsList of ExhibitsList of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)

Infographic





Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.